Research Article

Efficacy and Safety of Zhenyuan Capsule for Coronary Heart Disease with Abnormal Glucose and Lipid Metabolism: Study Protocol for a Randomized, Double-Blind, Parallel-Controlled, Multicenter Clinical Trial

Table 1

Measurement items and time points for data collection.

Screening Treatment period
T0Run-in period
(T1)
Week 4
(T2)
Week 8
(T3)
Week 12
(T4)

Basic medical history recording
Informed consent×
Inclusion/exclusion criteria×
Demographic data×
Medical and treatment history recording×
Complication and symptom recording×
Concomitant medication××××
Vital signs××××
Efficacy observation
TG, FBG, 2hPBG, and HbA1c levels×××××
TCM symptom indicators××××
Seattle Angina Questionnaire score××××
Coagulation indicator××××
P-selectin level××××
Angina pectoris scores and end-point event××××
ECG××
UCG××
Safety assessment
Liver and renal function tests×××××
Hemorrhage××××
Routine blood and urine tests××
Routine stool and occult blood tests××
Other works
Randomization and allocation×
Drug distribution×××
Medicine recycling and drug quantity statistics×××